These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 27506310)
1. Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. Reynolds K; An J; Wu J; Harrison TN; Wei R; Stuart B; Martin JP; Wlodarczyk CS; Rajpathak SN J Diabetes Complications; 2016; 30(8):1443-1451. PubMed ID: 27506310 [TBL] [Abstract][Full Text] [Related]
2. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Kalsekar ID; Madhavan SS; Amonkar MM; Douglas SM; Makela E; Elswick BL; Scott V Clin Ther; 2006 Feb; 28(2):306-18. PubMed ID: 16678652 [TBL] [Abstract][Full Text] [Related]
3. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent). Kalsekar I; Sheehan C; Peak A Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874 [TBL] [Abstract][Full Text] [Related]
4. Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Strongman H; D'Oca K; Langerman H; Das R Diabetes Obes Metab; 2015 Jun; 17(6):573-580. PubMed ID: 25735201 [TBL] [Abstract][Full Text] [Related]
5. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Hertz RP; Unger AN; Lustik MB Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485 [TBL] [Abstract][Full Text] [Related]
6. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768 [TBL] [Abstract][Full Text] [Related]
7. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy. Zhang Q; Zhao C; Davies MJ; Radican L; Seck T Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894 [TBL] [Abstract][Full Text] [Related]
8. Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database. Tanabe M; Motonaga R; Terawaki Y; Nomiyama T; Yanase T J Diabetes Investig; 2017 Mar; 8(2):227-234. PubMed ID: 27549920 [TBL] [Abstract][Full Text] [Related]
9. A systematic review of adherence with medications for diabetes. Cramer JA Diabetes Care; 2004 May; 27(5):1218-24. PubMed ID: 15111553 [TBL] [Abstract][Full Text] [Related]
10. Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences. Simon-Tuval T; Shmueli A; Harman-Boehm I Curr Med Res Opin; 2018 Feb; 34(2):345-351. PubMed ID: 29069921 [TBL] [Abstract][Full Text] [Related]
11. Discontinuation of statins among patients with type 2 diabetes. Lamberts EJ; Nijpels G; Welschen LM; Hugtenburg JG; Dekker JM; Souverein PC; Bouvy ML Diabetes Metab Res Rev; 2012 Mar; 28(3):241-5. PubMed ID: 21898755 [TBL] [Abstract][Full Text] [Related]
12. Weight change after initiation of oral hypoglycemic monotherapy for diabetes predicts 5-year mortality: An observational study. Kocarnik BM; Moore KP; Smith NL; Boyko EJ Diabetes Res Clin Pract; 2017 Jan; 123():181-191. PubMed ID: 28056429 [TBL] [Abstract][Full Text] [Related]
13. Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence? Kocarnik BM; Liu CF; Wong ES; Perkins M; Maciejewski ML; Yano EM; Au DH; Piette JD; Bryson CL BMC Health Serv Res; 2012 Nov; 12():391. PubMed ID: 23148570 [TBL] [Abstract][Full Text] [Related]
14. Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. Lee CS; Tan JHM; Sankari U; Koh YLE; Tan NC BMJ Open; 2017 Sep; 7(9):e016317. PubMed ID: 28912194 [TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization. Dalal MR; Kazemi M; Ye F; Xie L Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282 [TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas. Iglay K; Qiu Y; Steve Fan CP; Li Z; Tang J; Laires P Curr Med Res Opin; 2016 Sep; 32(9):1567-75. PubMed ID: 27175740 [TBL] [Abstract][Full Text] [Related]
17. Understanding medication adherence among patients of Turkish descent with type 2 diabetes: a qualitative study. Peeters B; Van Tongelen I; Duran Z; Yüksel G; Mehuys E; Willems S; Remon JP; Boussery K Ethn Health; 2015; 20(1):87-105. PubMed ID: 24588791 [TBL] [Abstract][Full Text] [Related]
18. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Savage S; Estacio RO; Jeffers B; Schrier RW Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587 [TBL] [Abstract][Full Text] [Related]
19. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens. Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148 [TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]